AstraZeneca has been facing a slump in sales following the loss of patent cover on antipsychotic Seroquel last month. Some of its best selling drugs – Nexium and Crestor would be loosing their patent protection in 2014 and 2016 respectively. While the company’s profits have fallen by 19 % in the first quarter the company…
about people, work, and workplaces